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studies have suggested both low vitamin E and selenium levels may be
risk factors for prostate cancer. However, a randomized, placebo-
controlled trial (Selenium and Vitamin E Cancer Prevention Trial [SE-
LECT]) of 35,533 men not only did not show any beneﬁcial effect of se-
lenium or vitamin E, alone or in combination on prevention of prostate
cancer in this population of relatively healthy men, but also suggestedOver the past decades, the incidence and prevalence of type 2 diabe-
tes (T2D) have increased spectacularly throughout the world, especially
in developing countries (Chen et al., 2011). T2D is associatedwithmany
complications, however, the chronic kidney disease, may be one of the However, if examined genetic factors, RCT approach cannot simply bemost devastating complications with respect to patient survival and
quality of life. The underlying mechanisms by which T2D may lead to
kidney damage are unclear. The prevalence of chronic kidney disease
(CKD) varies across populations with diabetes. For example, in the US,
according to the data from the 1999 through 2006 National Health
and Nutrition Examination Survey, in a representative sample of the
civilian, noninstitutionalized US population, nearly 40% of people with
diagnosed and 41.7% with undiagnosed diabetes had CKD; 17.7% with
prediabetes and 10.6% without diabetes had CKD (Plantinga et al.,
2010), while in a primary care setting in Finland, approximately 70%
of patients with T2D have some sign of CKD and about half of all T2D
patients have a signiﬁcant CKD (Metsärinne et al., 2015). Clearly, diabet-
ic kidney disease is now becoming a global public health concern.
In this issue of EBioMedicine, Xu et al. explored the causal association
between T2D and CKD in 11,502 participants, Shanghai, China. The
authors concluded that the relation between T2D and CKDmay be caus-
al (Xu et al., 2016). Observational epidemiological studies have already
identiﬁed T2D as a risk factor for CKD.Why is it important to establish a
causal relationship between T2D and CKD? The answer is that there is a
critical distinctionbetween a risk actor and a causal factor in thepreven-
tion of a disease: a risk factor can be identiﬁed from observational
studies, while a causal factor usually has to be established in a random-
ized clinical trial (RCT).
Observational studies usually suffer from selection bias since ran-
domization is not implemented. Not all ﬁndings derived from observa-
tional studies can be veriﬁed and conﬁrmed by RCT. In one meta-
analysis, up to one fourth of observational studies gave different resultsom.2016.02.032.
, Pathology#301, Baltimore,MD
. This is an open access article underthat there were marginally statistically increased risks of prostate can-
cer in the vitamin E group (Lippman et al., 2009).
Randomized clinical trials could be successfully used to examine
whether an environmental factor is causally associated with a disease.
utilized since it is impossible to perform randomization.
Xu et al. employed Mendelian randomization approach to conduct a
“pseudo” randomized trial to examine the causal association between
T2D and CKD (Xu et al., 2016). Mendelian randomization analysis has
major advantages in minimizing confounding and reverse causation.
In theory, this study should be almost identical to a RCT to test efﬁ-
cacy of a drug, except that the randomization in the drug trial is done
by investigators, while the “randomization” for studying an allele is
done by the random “assignment” of genes from parents to offspring,
thus, this randomization is called Mendelian randomization. In Xu
et al.'s study, a genetic risk score, GRS, summing up 34 established
T2D common variates in East Asia was used in this investigation (Xu
et al., 2016). The GRS is a single variable summarizing multiple genetic
variants associated with T2D. In Xu et al.'s study, the GRS (as an instru-
mental variable) was used to derive estimates of the causal effect of T2D
on CKD (Davey Smith and Ebrahim, 2003).
The ﬁndings of Xu et al.'s study demonstrated for the ﬁrst time that
the relationship between T2D and CKDwas potentially causal (Xu et al.,
2016). The strengths of this well-designed and painstakingly performed
investigation included a large sample size (N = 11,502), and an ethni-
cally homogenous study population. The Mendelian randomization
approach not only controlled for potential confounding factors by
employing GRS as proxies, but also excludes the possibility of reverse
causation (Lawlor et al., 2008).
Several limitations deserve attention. First, GRS is similar to a com-
posite exposure in a randomized clinical trial. Despite that a genetic
risk score has been used in Mendelian randomization analyses, utiliza-
tion of GRS has been challenged since (1) the individual variants of
the GRS may not be of similar importance to T2D, and (2) the more
important variants in the GRSmay be affected negatively. Furthermore,
since diabetic-associated CKD may continue to progress even after
blood glucose normalization, suggesting a metabolic memory of thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
11S. Lai / EBioMedicine 6 (2016) 10–11prior glycemic state, epigenetic studies are necessary to clarify the
mechanisms for metabolic memory (Villeneuve et al., 2011).
These limitations notwithstanding, the ﬁndings of Xu et al.'s study
may have important implications for the prevention of diabetic kidney
disease since a potential causal relationship between T2D and CKD has
been strongly suggested by this investigation.
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